Mirati Therapeutics CEO and Key Executives

Mirati Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of oncology products including candidates intended to treat specific genetic and epigenetic drivers of cancer in selected subsets of cancer patients with unmet needs.
Charles M. Baum

Charles M. Baum

President and CEO
Isan Chen

Isan Chen

Chief Medical and Development Officer
Chris Lemasters

Chris Lemasters

Chief Business Officer
James Christensen

James Christensen

Senior Vice President and Chief Scientific Officer
Jamie Donadio

Jamie Donadio

Senior Vice President and Chief Financial Officer
Perry C. Johnston

Perry C. Johnston

Vice President, Chief Legal and Compliance Officer, and Corporate Secretary
Vickie Reed

Vickie Reed

Vice President, Finance
Sanjeev Sharma

Sanjeev Sharma

Senior Vice President, Cmc and Product Development
Matthew Marx

Matthew Marx

Vice President and Head of Drug Discovery
Source:mirati.com